Ebos Group Ltd. (EBOSF)
OTC
Closed
Aug 21, 2026
Day's Range
23.7552 wk Range
22.44Overview - EBOSF - Ebos Group Ltd.
Key Statistics
Valuation
Enterprise Value
4.66B
P/E (Trailing)
‪34.92‬
Price / Sales (TTM)
‪0.36‬
Price / Book
‪2.51‬
EV / EBITDA
‪13.97‬
Profitability
Profit Margin
‪1.67%‬
Operating Margin
‪2.85%‬
Return on Assets
‪3.12%‬
Return on Equity
‪8.32%‬
Ownership
Shares Outstanding
203.23M
Float
196.87M
Held by Insiders
‪10.06%‬
Held by Institutions
‪21.51%‬
Price stats
Beta
‪0.15‬
50-Day Avg
‪23.75‬
200-Day Avg
‪23.75‬
Dividends
Payout Ratio
‪100.96%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - EBOSF - Ebos Group Ltd.
Peers - EBOSF - Ebos Group Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on OTC.
Profile Summary - EBOSF - Ebos Group Ltd.
About
Ebos Group Ltd. is a leading diversified wholesaler and distributor within the healthcare and animal care sectors across Australasia. The company plays a crucial role in the supply chain by delivering pharmaceuticals, medical equipment, and other healthcare-related products to hospitals, pharmacies, and healthcare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
